tiprankstipranks
Advertisement
Advertisement

INNMF Stock Latest News

Amplia lodges updated ASX corporate governance statement for 2026
Company AnnouncementsAmplia lodges updated ASX corporate governance statement for 2026
21h ago
Amplia Therapeutics details ASX-aligned corporate governance framework
PremiumCompany Announcements
Amplia Therapeutics details ASX-aligned corporate governance framework
23h ago
Amplia Highlights Cancer and Fibrosis Focus in 2025-26 Report
PremiumCompany Announcements
Amplia Highlights Cancer and Fibrosis Focus in 2025-26 Report
23h ago
Amplia Issues New Shares Under Executive Equity Plan, Affirms Regulatory Compliance
PremiumCompany Announcements
Amplia Issues New Shares Under Executive Equity Plan, Affirms Regulatory Compliance
18d ago
Amplia Therapeutics Adds 240,385 New Shares to ASX Listing
PremiumCompany Announcements
Amplia Therapeutics Adds 240,385 New Shares to ASX Listing
18d ago
Amplia and ANZGOG launch narmafotinib ovarian cancer trial targeting high‑need patients
PremiumCompany AnnouncementsAmplia and ANZGOG launch narmafotinib ovarian cancer trial targeting high‑need patients
22d ago
Amplia advances narmafotinib program with strong pancreatic cancer data and Phase 3 readiness steps
Premium
Company Announcements
Amplia advances narmafotinib program with strong pancreatic cancer data and Phase 3 readiness steps
1M ago
Amplia Halts New Recruitment in Pancreatic Cancer Trial After Chemo Toxicities
Premium
Company Announcements
Amplia Halts New Recruitment in Pancreatic Cancer Trial After Chemo Toxicities
2M ago
Amplia Halts AMPLICITY Recruitment, Shifts Focus to Less Toxic Pancreatic Cancer Regimens
PremiumCompany Announcements
Amplia Halts AMPLICITY Recruitment, Shifts Focus to Less Toxic Pancreatic Cancer Regimens
2M ago
Biotech Alert: Searches spiking for these stocks today
PremiumThe Fly
Biotech Alert: Searches spiking for these stocks today
2M ago
RADX
Biotech Alert: Searches spiking for these stocks today
PremiumThe Fly
Biotech Alert: Searches spiking for these stocks today
2M ago
Amplia posts unprecedented complete responses and survival gain in pancreatic cancer trial
PremiumCompany Announcements
Amplia posts unprecedented complete responses and survival gain in pancreatic cancer trial
2M ago
Amplia requests ASX trading halt ahead of key clinical trial data
PremiumCompany AnnouncementsAmplia requests ASX trading halt ahead of key clinical trial data
2M ago
Amplia Therapeutics Reappoints Experienced CFO to Support Biotech Growth
Premium
Company Announcements
Amplia Therapeutics Reappoints Experienced CFO to Support Biotech Growth
3M ago
Amplia Expands U.S. Footprint With New Sites for Pancreatic Cancer Trial
Premium
Company Announcements
Amplia Expands U.S. Footprint With New Sites for Pancreatic Cancer Trial
4M ago
Amplia Secures Phase 3-Ready Supply with First Large-Scale Narmafotinib Manufacture
PremiumCompany Announcements
Amplia Secures Phase 3-Ready Supply with First Large-Scale Narmafotinib Manufacture
4M ago
Amplia Showcases Promising Pancreatic Cancer Data for Narmafotinib at ASCO GI
PremiumCompany Announcements
Amplia Showcases Promising Pancreatic Cancer Data for Narmafotinib at ASCO GI
5M ago
Amplia Deepens Next & Bio Collaboration to Test Narmafotinib–kRAS Combo in Pancreatic Cancer
PremiumCompany Announcements
Amplia Deepens Next & Bio Collaboration to Test Narmafotinib–kRAS Combo in Pancreatic Cancer
5M ago
Amplia Therapeutics Reports Positive ACCENT Trial Results for Pancreatic Cancer
PremiumCompany Announcements
Amplia Therapeutics Reports Positive ACCENT Trial Results for Pancreatic Cancer
6M ago
Amplia Therapeutics Reports Promising Trial Results for Pancreatic Cancer Drug
PremiumCompany AnnouncementsAmplia Therapeutics Reports Promising Trial Results for Pancreatic Cancer Drug
6M ago
Amplia Therapeutics Receives FDA Support for Pancreatic Cancer Trial
Premium
Company Announcements
Amplia Therapeutics Receives FDA Support for Pancreatic Cancer Trial
6M ago
Amplia Therapeutics Issues New Equity Securities
Premium
Company Announcements
Amplia Therapeutics Issues New Equity Securities
7M ago

Trending

Name
Price
Price Change
SPX
S&P 500
―
DJIA
Dow Jones
―
NDX
Nasdaq 100
―
More Trending Stocks >